Home / News / Forecast 2023 China Medical Endoscope Industry Market Size

Forecast 2023 China Medical Endoscope Industry Market Size

Views: 0     Author: Site Editor     Publish Time: 2023-12-12      Origin: Site


facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button
Forecast 2023 China Medical Endoscope Industry Market Size

Core data of this paper: 

Penetration rate of minimally invasive surgery, proportion of cancer incidence and death, market size and forecast of medical endoscope industry


1, Definition: medical endoscopes are widely used and rich in variety:

A medical endoscope is a medical imaging device used to provide access, illumination, and the ability to observe or manipulate body cavities, hollow organs, and body ducts during endoscopic procedures. The clinical application of medical endoscope can be divided into two aspects: diagnosis and treatment. When entering the body through the natural pores or surgical incisions of the human body, the diagnostic function is mainly to help the doctor make disease diagnosis after observation or take a lesion biopsy for pathological diagnosis, while the therapeutic function is used for specific operations or to assist the implantation of therapeutic artificial products.

Medical endoscopes are widely used and have a wide variety, which can be roughly classified from the three dimensions of imaging principle, use times and product structure. According to the imaging principle, they can be divided into electronic medical endoscopes and optical medical endoscopes. According to the number of use, it can be divided into reusable medical endoscopes and disposable medical endoscopes. According to the product structure classification can be divided into rigid medical endoscope and soft medical endoscope.

2. Industrial chain: Middle and upstream enterprises are the core engine of value creation in the entire industrial chain

The industrial chain of medical endoscope industry can be divided into three links. The upstream participants are raw material and parts manufacturers, mainly including raw material manufacturers, optical parts manufacturers, mechanical parts manufacturers, and electronic component manufacturers. The midstream participants are medical endoscope manufacturers, including rigid medical endoscope manufacturers, soft medical endoscope manufacturers, etc. Downstream for medical institutions and clinical departments.

3. The representative enterprises in the upstream industry include Shenzhou Medical, Yunrui Medical, Jingneng Plastic mold and Qiqi Photoelectric and light module manufacture Rayfine, etc. Representative enterprises in the midstream industry include Kaixin Medical, Aohua Endoscopy, Haitai Xinguang, Mindray Medical, etc.; Downstream are mainly medical institutions and clinical departments.

4. Industry policy background: Policy support ushered in new opportunities for development.

Since 2018, various departments have issued a series of policies aimed at promoting the development of medical endoscopy technology. These policies include deepening the reform of the medical and health system, accelerating the review and approval of drugs and medical devices, supporting technological innovation in endoscopic surgery, encouraging the purchase of domestic medical devices, and promoting independent innovation in medical devices. These policies provide solid national policy support for the application and development of endoscopic technology.

Industry development status:

1. Endoscope combined with minimally invasive surgical instruments and surgical equipment promotes minimally invasive surgery.

The endoscope, combined with minimally invasive surgical instruments and surgical equipment, promotes minimally invasive surgery and injects new impetus to the innovation and development of traditional surgery.

Minimally invasive surgery refers to the surgery performed under the condition of small incision or no incision, which mainly covers the three sub-fields of minimally invasive surgery, minimally invasive operation and other minimally invasive surgery. Minimally invasive techniques with endoscopic system as the core have been popularized in many departments, such as general surgery, obstetrics and gynecology, gastroenterology, etc. Minimally invasive surgery mainly uses rigid endoscope. After clinical diagnosis of internal organs, minimally invasive surgical instruments and equipment are manipulated in vitro to perform surgical operations on diseased tissues, such as laparoscopic surgery using laparoscopy, thoracoscopy and hysteroscopy. Among them, laparoscopy is the mainstream minimally invasive surgery platform, which is the most widely used and the most frequently used variety in the classification of hard mirrors.

In view of the obvious advantages of minimally invasive surgery, more and more attention and recognition, gradually replace the traditional open surgery has become an inevitable trend. The penetration rate of minimally invasive surgery in China continues to rise, from 8.8% to 14.2% from 2016 to 2021, and approximately 15.1% in 2022. Compared with European and American countries, minimally invasive surgery is still in its infancy in China. With the improvement of patients' cognition and acceptance of minimally invasive surgery, the enhancement of doctors' operating techniques and the expansion of clinical application fields, the penetration space of minimally invasive surgery is expected to be further improved. At the same time, the development of minimally invasive surgery has entered the stage of expanding the scope of popularization, and the substantial growth in the number of surgeries will also promote the innovation and improvement of endoscopic technology to achieve better efficacy.

2. Digestive tract diagnosis is the main application field of soft mirror, and soft mirror screening is an important way to control digestive tract diseases and improve survival rate.

In 2022, the incidence of gastric cancer, esophageal cancer, colorectal cancer and pancreatic cancer in China accounted for 28.49% of the number of new cancers, and the number of deaths accounted for about 31.77%. Gastrointestinal cancer has made China bear a huge medical and economic burden. Early screening is an effective method to strengthen the early diagnosis of gastrointestinal cancer, and timely detection of precancerous lesions and early tumors can significantly reduce the incidence and mortality of cancer. The prognosis of gastrointestinal cancer is closely related to the timing of diagnosis and treatment. Taking colon cancer as an example, it generally evolves from precancerous lesions such as large intestine polyps and adenomas. The development process is relatively slow, and early detection and treatment have a long window period. Taking gastric cancer as an example, at present, 90% of gastric cancer found in our country is advanced, and the 5-year survival rate of patients with advanced gastric cancer receiving surgical treatment is still less than 30%, while the 5-year survival rate of early gastric cancer receiving timely treatment is expected to be significantly improved, or more than 90%.

3. In 2022, the market size of China's medical endoscope industry will be about 27.8 billion RMB.

Endoscopes are indispensable diagnostic and surgical equipment in general surgery, urology, otolaryngology, orthopedics, gynecology and other departments, and are also one of the fastest growing product types in the global medical device industry. Endoscope applications in overseas developed countries are widely based, while China's medical endoscope market is still in a stage of rapid development. Driven by the establishment of China's hierarchical diagnosis and treatment system, the development of minimally invasive surgery, the gradual improvement of physician training system and other factors, the scale of China's medical endoscope market will expand rapidly at a rate higher than that of the world. In 2021, the market size of China's medical endoscope was 24.8 billion yuan, an increase of 45.0% compared to 2017, and the market size was about 27.8 billion yuan in 2022.


In 2028, the market size of China's medical endoscope industry will exceed 50 billion RMB.

Driven by positive factors such as policy, market and technology, China's medical endoscope industry is expected to usher in sustained and rapid development. By 2028, the market size of China's medical endoscope industry will exceed 50 billion RMB, reaching 51.1 billion RMB, and the compound growth rate of 2023-2028 will be 10.41%, with broad market prospects. In 2028, the market size of China's medical endoscope industry will exceed 50 billion RMB.

Contact Us

Rayfine Technologies Co., Ltd.
   8F, W2 Bldg, Tian'An Shenchuanggu, 178 Dongshen Road, Dongguan, Guangdong, China 523690
  Tel: +86-13059548953
Follow Us
Leave a Message
Contact Us
 Copyright © 2023 Rayfine All Rights Reserved. Sitemap | Support By Leadong 粤ICP备2023000547号